SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001711279-22-000058
Filing Date
2022-11-07
Accepted
2022-11-07 07:11:56
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q krys-20220930.htm   iXBRL 10-Q 1184887
2 EX-31.1 krys-20220930ex311.htm EX-31.1 10788
3 EX-31.2 krys-20220930ex312.htm EX-31.2 10751
4 EX-32.1 krys-20220930ex321.htm EX-32.1 11272
10 krys-20220930_g1.jpg GRAPHIC 216998
  Complete submission text file 0001711279-22-000058.txt   6200151

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20220930.xsd EX-101.SCH 36952
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT krys-20220930_cal.xml EX-101.CAL 56023
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krys-20220930_def.xml EX-101.DEF 143040
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20220930_lab.xml EX-101.LAB 477050
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20220930_pre.xml EX-101.PRE 299612
52 EXTRACTED XBRL INSTANCE DOCUMENT krys-20220930_htm.xml XML 1045078
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38210 | Film No.: 221363700
SIC: 2836 Biological Products, (No Diagnostic Substances)